Company profile: HumanCode
1.1 - Company Overview
Company description
- Provider of next-generation personal genomics applications and a platform using DNA sequencing to deliver personalized insights that help people make better decisions, combining human-centered design, mobile, and machine-learning technologies to reveal the secrets of the human genome.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HumanCode
Gateway Genomics
HQ: France
Website
- Description: Provider of genetically based tests for families and cancer care, including SneakPeek Early Gender Test to determine fetal sex from a small maternal blood sample as early as six weeks; Foresight Carrier Screen for inherited conditions; Prequel Prenatal Screen to identify risk of chromosomal conditions like Down syndrome from week 10; and oncology tests Prolaris and Precise to assess prostate cancer aggressiveness and tumor variants to guide treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gateway Genomics company profile →
Verve Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage genetic medicines for cardiovascular disease, including gene editing therapies VERVE-101 targeting PCSK9 to lower LDL-C in heterozygous familial hypercholesterolemia and ASCVD, and VERVE-201 targeting ANGPTL3 for homozygous and refractory hypercholesterolemia, enabled by a proprietary GalNAc-LNP liver delivery system, with medicines evaluated in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verve Therapeutics company profile →
Loop Genomics
HQ: United States
Website
- Description: Provider of platform technology for long-read DNA sequencing that transforms short-read DNA sequencers into high-throughput, long-read, single-molecule systems, delivering phased sequencing solutions for research and clinical applications. Solutions include the AVITI System (high accuracy, low run costs, dual flow cells), Teton CytoProfiling with AVITI24, and Avidity Base Chemistry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Loop Genomics company profile →
Lexent Bio
HQ: United States
Website
- Description: Provider of novel liquid biopsy technology for cancer diagnosis and treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexent Bio company profile →
Evonetix
HQ: United Kingdom
Website
- Description: Provider of a benchtop platform that synthesizes, assembles, and error-corrects gene-length DNA on a silicon chip with unprecedented accuracy and scale using thermal control of DNA synthesis. Offers chip technology to synthesize thousands of oligonucleotide sequences simultaneously, binary assembly, and thermal error removal for rapid, precise gene synthesis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evonetix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HumanCode
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HumanCode
2.2 - Growth funds investing in similar companies to HumanCode
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HumanCode
4.2 - Public trading comparable groups for HumanCode
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →